Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients

[1]  F. Gage,et al.  Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice , 2008, BMC Neuroscience.

[2]  E. Koo,et al.  Amyloid Precursor Protein Trafficking, Processing, and Function* , 2008, Journal of Biological Chemistry.

[3]  C. Glabe,et al.  Structural Classification of Toxic Amyloid Oligomers* , 2008, Journal of Biological Chemistry.

[4]  R. Kayed,et al.  Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin , 2008, Molecular Neurodegeneration.

[5]  E. Masliah,et al.  Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases , 2008, PloS one.

[6]  D. Selkoe,et al.  Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.

[7]  T. Wisniewski,et al.  Amyloid-β immunisation for Alzheimer's disease , 2008, The Lancet Neurology.

[8]  Brian Spencer,et al.  The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. , 2008, The Journal of clinical investigation.

[9]  E. Masliah,et al.  Activation of the Amyloid Cascade in Apolipoprotein E4 Transgenic Mice Induces Lysosomal Activation and Neurodegeneration Resulting in Marked Cognitive Deficits , 2008, The Journal of Neuroscience.

[10]  G. Rebeck,et al.  Regulated Proteolysis of APP and ApoE Receptors , 2008, Molecular Neurobiology.

[11]  S. Love,et al.  Abeta-degrading enzymes in Alzheimer's disease. , 2008, Brain pathology.

[12]  M. Wolfe.  Gamma-secretase inhibition and modulation for Alzheimer's disease. , 2008, Current Alzheimer research.

[13]  R. Postina.  A closer look at alpha-secretase. , 2008, Current Alzheimer research.

[14]  N. Belyaev,et al.  Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease. , 2008, Current Alzheimer research.

[15]  A. Cuello,et al.  Impact of Intracellular β-Amyloid in Transgenic Animals and Cell Models , 2008, Neurodegenerative Diseases.

[16]  D. Sulzer,et al.  Methamphetamine Inhibits Antigen Processing, Presentation, and Phagocytosis , 2008, PLoS pathogens.

[17]  B. Ances,et al.  Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders , 2008, International review of psychiatry.

[18]  E. Masliah,et al.  Neurobiology of HIV , 2008, International review of psychiatry.

[19]  V. Mollace,et al.  N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunction , 2007, BMC Neuroscience.

[20]  M. Alizon,et al.  Identification of a Postendocytic Sorting Sequence in CCR5 , 2007, Molecular Pharmacology.

[21]  Ralph A. Nixon,et al.  Autophagy, amyloidogenesis and Alzheimer disease , 2007, Journal of Cell Science.

[22]  M. Findeis.  The role of amyloid β peptide 42 in Alzheimer's disease , 2007 .

[23]  M. Szyf,et al.  High intracellular concentrations of amyloid‐beta block nuclear translocation of phosphorylated CREB , 2007, Journal of neurochemistry.

[24]  Long-chuan Yu,et al.  The role of intracellular amyloid β in Alzheimer's disease , 2007, Progress in Neurobiology.

[25]  Maria Flora Salvatori,et al.  Persistence of Neuropsychologic Deficits Despite Long-TermHighlyActiveAntiretroviralTherapyinPatients With HIV-Related Neurocognitive Impairment: Prevalence and Risk Factors , 2007, Journal of acquired immune deficiency syndromes.

[26]  Marinos C. Dalakas,et al.  β‐Amyloid is a substrate of autophagy in sporadic inclusion body myositis , 2007 .

[27]  D. Selkoe,et al.  The APP family of proteins: similarities and differences. , 2007, Biochemical Society transactions.

[28]  E. V. Bockstaele,et al.  Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis , 2006, Gene Therapy.

[29]  J. Corbeil,et al.  Diminished somatostatin gene expression in individuals with HIV and major depressive disorder , 2006, Neurology.

[30]  W. Banks,et al.  A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells , 2006, Experimental Neurology.

[31]  K. Jellinger.  Challenges in neuronal apoptosis. , 2006, Current Alzheimer research.

[32]  B. Levine,et al.  HIV and CXCR4 in a kiss of autophagic death. , 2006, The Journal of clinical investigation.

[33]  P. Gorry,et al.  Mechanisms of HIV-1 neurotropism. , 2006, Current HIV research.

[34]  M. Wolfe.  The γ-Secretase Complex: Membrane-Embedded Proteolytic Ensemble , 2006 .

[35]  J. Busciglio,et al.  Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons , 2006, The Journal of Neuroscience.

[36]  J. Marcusson,et al.  Oxidative Stress Induces Intralysosomal Accumulation of Alzheimer Amyloid β‐Protein in Cultured Neuroblastoma Cells , 2006, Annals of the New York Academy of Sciences.

[37]  D. Dickson,et al.  β-Amyloid Degradation and Alzheimer's Disease , 2006, Journal of biomedicine & biotechnology.

[38]  J. Standridge.  Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease. , 2006, Current Alzheimer research.

[39]  Gopal Thinakaran,et al.  Amyloidogenic processing of β-amyloid precursor protein in intracellular compartments , 2006, Neurology.

[40]  Y. Lyubchenko,et al.  Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease , 2005, Neurological research.

[41]  N. Kumaragurubaran,et al.  Recent Developments of Structure Based β-Secretase Inhibitors for Alzheimers Disease , 2005 .

[42]  P. Keller,et al.  Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease , 2005 .

[43]  C. Eckman,et al.  Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention , 2005 .

[44]  L. Tjernberg,et al.  Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease , 2005, The Journal of cell biology.

[45]  E. Masliah,et al.  Lysosomal pathology associated with α‐synuclein accumulation in transgenic models using an eGFP fusion protein , 2005, Journal of neuroscience research.

[46]  Jill A. White,et al.  Differential effects of oligomeric and fibrillar amyloid-β1–42 on astrocyte-mediated inflammation , 2005, Neurobiology of Disease.

[47]  G. Schettini,et al.  The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications , 2005, Brain Research Reviews.

[48]  E. Masliah,et al.  Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients , 2005, AIDS.

[49]  Lynn Pulliam,et al.  HIV-1 Tat inhibits neprilysin and elevates amyloid β , 2005 .

[50]  L. Hersh,et al.  Tat and amyloid: multiple interactions. , 2005, AIDS.

[51]  O. Selnes,et al.  Diabetes, Insulin Resistance, and Dementia Among HIV-1-Infected Patients , 2005, Journal of acquired immune deficiency syndromes.

[52]  A. Cuello.  Intracellular and Extracellular Aβ, a Tale of Two Neuropathologies , 2005, Brain pathology.

[53]  Y. Liu,et al.  Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort , 2004, Journal of Neuroimmunology.

[54]  B. Lamb,et al.  Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. , 2004, The international journal of biochemistry & cell biology.

[55]  E. Masliah,et al.  Altered P‐Glycoprotein Expression in AIDS Patients with HIV Encephalitis , 2004, Journal of neuropathology and experimental neurology.

[56]  O. Selnes,et al.  Higher frequency of dementia in older HIV-1 individuals , 2004, Neurology.

[57]  L. Pulliam,et al.  P3-371 HIV-1 TAT inhibits neprilysin and elevates amyloid beta , 2004, Neurobiology of Aging.

[58]  V. Valcour,et al.  HIV-associated dementia, mitochondrial dysfunction, and oxidative stress. , 2004, Mitochondrion.

[59]  Christina A. Wilson,et al.  Degradative organelles containing mislocalized α- and β-synuclein proliferate in presenilin-1 null neurons , 2004, The Journal of cell biology.

[60]  J. Becker,et al.  Prevalence of cognitive disorders differs as a function of age in HIV virus infection , 2004, AIDS.

[61]  A. Takashima,et al.  Specific Compositions of Amyloid-β Peptides as the Determinant of Toxic β-Aggregation* , 2003, Journal of Biological Chemistry.

[62]  J. Garcia,et al.  Inhibition of Endosomal/Lysosomal Degradation Increases the Infectivity of Human Immunodeficiency Virus , 2002, Journal of Virology.

[63]  A. Cuello,et al.  Intracellular A-beta amyloid, A sign for worse things to come? , 2002, Molecular Neurobiology.

[64]  V. Perry,et al.  Accumulation of β‐Amyloid Precursor Protein in Axons Correlates with CNS Expression of SIV gp41 , 2002 .

[65]  M. Mallory,et al.  Early formation of mature amyloid‐β protein deposits in a mutant APP transgenic model depends on levels of Aβ1–42 , 2001, Journal of neuroscience research.

[66]  M. Grassi,et al.  Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients , 2001, AIDS.

[67]  P. Stopka,et al.  Quinolinic acid — Iron(II) complexes: Slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction , 2001, Free radical research.

[68]  D. Cooper,et al.  Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study , 1999, The Lancet.

[69]  Chrétien,et al.  Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage , 1999, Neuropathology and applied neurobiology.

[70]  M. Esiri,et al.  Prevalence of Alzheimer plaques in AIDS , 1998, Journal of neurology, neurosurgery, and psychiatry.

[71]  F. Scaravilli,et al.  Axonal Damage Revealed by Accumulation of β‐APP in HIV‐positive Individuals without AIDS , 1997, Journal of neuropathology and experimental neurology.

[72]  F. Scaravilli,et al.  Accumulation of β‐amyloid precursor protein in HIV encephalitis: Relationship with neuropsychological abnormalities , 1997 .

[73]  M. Esiri,et al.  Cerebral white matter damage in HIV infection demonstrated using β-amyloid precursor protein immunoreactivity , 1997, Acta Neuropathologica.

[74]  R. Mrak,et al.  Glial Cytokines as Neuropathogenic Factors in HIV Infection: Pathogenic Similarities to Alzheimer's Disease , 1994, Journal of neuropathology and experimental neurology.

[75]  C. Achim,et al.  Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. , 1993, The Journal of clinical investigation.

[76]  D. Dickson,et al.  Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease , 1993, Glia.

[77]  E. Masliah,et al.  Spectrum of human immunodeficiency virus–associated neocortical damage , 1992, Annals of neurology.

[78]  L. Hersh,et al.  Tat peptides inhibit neprilysin , 2011, Journal of NeuroVirology.

[79]  K. Roth,et al.  The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy. , 2008, Frontiers in bioscience : a journal and virtual library.

[80]  M. Wolfe.  Gamma-secretase: structure, function, and modulation for Alzheimer's disease. , 2008, Current topics in medicinal chemistry.

[81]  J. Lünemann,et al.  Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis. , 2007, Annals of neurology.

[82]  Howard E Gendelman,et al.  Oxidative stress and the pathogenesis of neurodegenerative disorders. , 2007, International review of neurobiology.

[83]  Long-chuan Yu,et al.  The role of intracellular amyloid beta in Alzheimer's disease. , 2007, Progress in neurobiology.

[84]  M. Findeis.  The role of amyloid beta peptide 42 in Alzheimer's disease. , 2007, Pharmacology & therapeutics.

[85]  M. Wolfe.  The gamma-secretase complex: membrane-embedded proteolytic ensemble. , 2006, Biochemistry.

[86]  D. Rubinsztein,et al.  Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. , 2006, Current topics in developmental biology.

[87]  P. Keller,et al.  Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. , 2005, Journal of neurochemistry.

[88]  C. Eckman,et al.  Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. , 2005, Biochemical Society transactions.

[89]  N. Kumaragurubaran,et al.  Recent developments of structure based beta-secretase inhibitors for Alzheimer's disease. , 2005, Current topics in medicinal chemistry.

[90]  V. Valcour,et al.  Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. , 2004, AIDS.

[91]  A. Takashima,et al.  Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation. , 2003, The Journal of biological chemistry.

[92]  K. Jellinger,et al.  Problems of cell death in neurodegeneration and Alzheimer's Disease. , 2001, Journal of Alzheimer's disease : JAD.

[93]  E. Iżycka-Świeszewska,et al.  Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS). , 2000, Folia neuropathologica.

[94]  M. Szyf,et al.  Aß Immunoreactive Material Is Present in Several Intracellular Compartments in Transfected, Neuronally Differentiated, P19 Cells Expressing the Human Amyloid ß-Protein Precursor , 2000 .

[95]  M. Szyf,et al.  Abeta immunoreactive material is present in several intracellular compartments in transfected, neuronally differentiated, P19 cells expressing the human amyloid beta-protein precursor. , 2000, Journal of Alzheimer's disease : JAD.

[96]  A. Roses,et al.  CELLULAR LOCALIZATION OF MESSENGER RNA ENCODING AMYLOID‐BETA-PROTEIN IN NORMAL TISSUE AND IN ALZHEIMER DISEASE , 1988, Alzheimer disease and associated disorders.